Use of Regenerative Medicine in Cancer Therapeutics to Anchor Growth in Biotherapeutics Cell Line Development Market
Prevalence of chronic disorders such as neurological ailments, cancers, and diabetes remain primary contributors for the growth of biotherapeutics cell line development market. Adoption of novel therapeutics such as cell biology and in-vitro cell culture have emerged as novel treatment means to address aforementioned ailments. Government initiatives supporting adoption of monoclonal antibodies as potent therapeutics is also likely to aid growth in biotherapeutics cell line development market in the coming years.
View full press release